Klebl; Bert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klebl; Bert.The latest application filed is for "coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer".

Company Profile

3.11.25

Klebl; Bert - Dortmund DE
Klebl; Bert - Oberschweinbad DE
Klebl; Bert - Oberschweinbach DE
KLEBL; Bert - Gunzlhofen DE
Klebl; Bert - Munchen DE
Klebl; Bert - Obesschweinbad DE
Klebl; Bert - Gunzelhofen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer Grant 11,111,238 - Di Lucrezia , et al. September 7, 2	2021-09-07
Coumarin Derivatives, Processes For Their Preparation And Uses Thereof For The Treatment Of Cancer App 20200291011 - Di Lucrezia; Raffaella ; et al.	2020-09-17
4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer Grant 10,703,735 - Di Lucrezia , et al.	2020-07-07
4-phenyl-coumarin Derivatives, Processes For Their Preparation And Uses Thereof For The Treatment Of Cancer App 20200031794 - Di Lucrezia; Raffaella ; et al.	2020-01-30
Pharmaceutically active disubstituted pyridine derivatives Grant 9,242,937 - Ruhter , et al. January 26, 2	2016-01-26
Cdk9 Inhibitors In The Treatment Of Midline Carcinoma App 20150329537 - Choidas; Axel ; et al.	2015-11-19
Pharmaceutically active compounds as Axl inhibitors Grant 8,999,982 - Schultz-Fademrecht , et al. April 7, 2	2015-04-07
Cdk9 Inhibitors In The Treatment Of Midline Carcinoma App 20140303167 - Choidas; Axel ; et al.	2014-10-09
Pharmaceutically Active Disubstituted Pyridine Derivatives App 20140296304 - Ruhter; Gerd ; et al.	2014-10-02
Susceptibility To Selective Cdk9 Inhibitors App 20140287454 - Choidas; Axel ; et al.	2014-09-25
Pharmaceutically Active Compounds As Axl Inhibitors App 20140018365 - Schultz-Fademrecht; Carsten ; et al.	2014-01-16
4,6-disubstituted Aminopyrimidine Derivatives As Inhibitors Of Protein Kinases App 20130338147 - Wabnitz; Philipp ; et al.	2013-12-19
4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases Grant 8,507,498 - Wabnitz , et al. August 13, 2	2013-08-13
Pharmaceutically Active Disubstituted Triazine Derivatives App 20130079345 - Eickhoff; Jan ; et al.	2013-03-28
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases Grant 8,084,457 - Choidas , et al. December 27, 2	2011-12-27
4, 6-disubstituted Aminopyrimidine Derivatives As Inhibitors Of Protein Kinases App 20110306602 - Wabnitz; Philipp ; et al.	2011-12-15
Novel C. Elegans P21-activated Kinase (pak) Gene And Associated Loss-of-function Phenotypes That Facilitate Screening For Small Molecule Modulators Of Pak Activity In The Nematode, Caenorhabditis Elegans App 20080213798 - GRANDIEN; Kaj ; et al.	2008-09-04
Napthyridine Compounds As Rock Inhibitors App 20080207677 - Muller; Stefan ; et al.	2008-08-28
Pyrimidine Derivatives App 20080187575 - Klebl; Bert ; et al.	2008-08-07
Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor Grant 7,341,717 - Herget , et al. March 11, 2	2008-03-11
C. elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of PAK activity in the nematode, caenorhabditis elegans Grant 7,319,024 - Grandien , et al. January 15, 2	2008-01-15
Heterobicyclic Compounds as Pharmaceutically Active Agents App 20070275962 - Koul; Anil ; et al.	2007-11-29
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases App 20070191344 - Choidas; Axel ; et al.	2007-08-16
Formulations useful against hepatitis C virus infections App 20060151574 - Herget; Thomas ; et al.	2006-07-13
Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins App 20060105445 - Godl; Klaus ; et al.	2006-05-18
Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor App 20040152073 - Herget, Thomas ; et al.	2004-08-05
Method for generating a genetically modified organism App 20040143854 - Klebl, Bert ; et al.	2004-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.